• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

司库奇尤单抗与阿维A联合治疗泛发性脓疱型银屑病:一例病例报告及文献复习

Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.

作者信息

Li Ji, Wang Shiyu, Li Xiao-Dong, Han Yang

机构信息

Department of Dermatology, Central Hospital Affiliated To ShenYang Medical College, 5 Nanqi West Road, 110024, Shenyang, Liaoning, China.

出版信息

J Int Med Res. 2024 Apr;52(4):3000605241247702. doi: 10.1177/03000605241247702.

DOI:10.1177/03000605241247702
PMID:38661102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11047231/
Abstract

Generalized pustular psoriasis (GPP) is characterized by painful and occasionally disfiguring cutaneous manifestations with sepsis-like systemic symptoms, and is a rare severe variant of psoriasis. Currently, there is no standard treatment for GPP. Here, we report a case of a female patient with ankylosing spondylitis (AS) and mild scalp psoriasis, who developed GPP and alopecia following three courses of adalimumab therapy. The patient's condition gradually improved following cessation of adalimumab and treatment with secukinumab and acitretin. After eight weeks of treatment, the patient achieved almost complete clearance of her psoriasis, her alopecia improved, and her AS was relieved. Therefore, we believe that a combination of secukinumab with acitretin may be a rational approach for the treatment of severe GPP.

摘要

泛发性脓疱型银屑病(GPP)的特征是伴有类似败血症的全身症状的疼痛性且偶尔会毁容的皮肤表现,是银屑病的一种罕见严重变体。目前,GPP尚无标准治疗方法。在此,我们报告一例患有强直性脊柱炎(AS)和轻度头皮银屑病的女性患者,在接受三个疗程的阿达木单抗治疗后发生了GPP和脱发。停用阿达木单抗并使用司库奇尤单抗和阿维A治疗后,患者的病情逐渐改善。经过八周的治疗,患者的银屑病几乎完全清除,脱发有所改善,AS也得到缓解。因此,我们认为司库奇尤单抗与阿维A联合使用可能是治疗重度GPP的合理方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/210f959e9331/10.1177_03000605241247702-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/2ada508e775b/10.1177_03000605241247702-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/55620995d827/10.1177_03000605241247702-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/210f959e9331/10.1177_03000605241247702-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/2ada508e775b/10.1177_03000605241247702-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/55620995d827/10.1177_03000605241247702-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63ef/11047231/210f959e9331/10.1177_03000605241247702-fig3.jpg

相似文献

1
Combination of secukinumab and acitretin for generalized pustular psoriasis: A case report and review of literature.司库奇尤单抗与阿维A联合治疗泛发性脓疱型银屑病:一例病例报告及文献复习
J Int Med Res. 2024 Apr;52(4):3000605241247702. doi: 10.1177/03000605241247702.
2
Successful treatment of paediatric generalized pustular psoriasis with secukinumab: a case series.成功使用司库奇尤单抗治疗儿童泛发性脓疱型银屑病:病例系列。
J Dermatolog Treat. 2022 May;33(3):1769-1773. doi: 10.1080/09546634.2021.1899111. Epub 2021 Mar 11.
3
Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.司库奇尤单抗和阿维A在儿童泛发性脓疱型银屑病治疗中的真实世界数据。
J Dermatol. 2023 Feb;50(2):258-261. doi: 10.1111/1346-8138.16551. Epub 2022 Aug 18.
4
Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin.对阿达木单抗和阿维A联合治疗有效的难治性泛发性脓疱型银屑病
Int J Dermatol. 2013 Dec;52(12):1610-1. doi: 10.1111/j.1365-4632.2012.05472.x. Epub 2012 Jul 27.
5
Successful treatment of acrodermatitis continua of Hallopeau coexisting with generalized pustular psoriasis with spesolimab: a case report.司库奇尤单抗成功治疗合并泛发性脓疱型银屑病的Hallopeau连续性肢端皮炎:一例报告
Front Immunol. 2024 Feb 23;15:1338285. doi: 10.3389/fimmu.2024.1338285. eCollection 2024.
6
Acitretin is a safe treatment option for infantile pustular psoriasis.阿维A是治疗婴儿脓疱型银屑病的一种安全选择。
J Dermatolog Treat. 2008;19(6):341-3. doi: 10.1080/09546630802132643.
7
Successful treatment of refractory juvenile generalized pustular psoriasis with secukinumab monotherapy: A case report and review of published work.成功使用司库奇尤单抗单药治疗难治性青少年泛发性脓疱型银屑病:一例病例报告及文献复习。
J Dermatol. 2018 Nov;45(11):1353-1356. doi: 10.1111/1346-8138.14636. Epub 2018 Sep 19.
8
Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile.司库奇尤单抗联合阿维 A 治疗多种药物难治性重症银屑病三种临床类型的疗效和安全性:一项高效安全的病例系列研究。
Dermatol Ther. 2021 Jan;34(1):e14704. doi: 10.1111/dth.14704. Epub 2021 Jan 3.
9
Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review.阿达木单抗治疗儿童泛发性脓疱型银屑病的疗效:病例系列及文献综述
J Dermatolog Treat. 2022 Sep;33(6):2862-2868. doi: 10.1080/09546634.2022.2089327. Epub 2022 Jun 20.
10
Successful treatment of generalized pustular psoriasis with guselkumab.古塞单抗成功治疗泛发性脓疱型银屑病。
J Dermatolog Treat. 2024 Dec;35(1):2331807. doi: 10.1080/09546634.2024.2331807. Epub 2024 Mar 24.

本文引用的文献

1
Human Leukocyte Antigen Markers for Distinguishing Pustular Psoriasis and Adult-Onset Immunodeficiency with Pustular Reaction.用于鉴别脓疱型银屑病和伴有脓疱反应的成人免疫缺陷的人类白细胞抗原标志物。
Genes (Basel). 2024 Feb 23;15(3):278. doi: 10.3390/genes15030278.
2
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.掌跖脓疱病:风险因素与治疗的系统评价
Psoriasis (Auckl). 2023 Sep 22;13:33-58. doi: 10.2147/PTT.S400402. eCollection 2023.
3
Current management of generalized pustular psoriasis.泛发性脓疱型银屑病的治疗现状。
Exp Dermatol. 2023 Aug;32(8):1204-1218. doi: 10.1111/exd.14765. Epub 2023 Mar 1.
4
Generalized Pustular Psoriasis: A Review of the Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment.泛发性脓疱型银屑病:发病机制、临床表现、诊断和治疗的综述。
Cutis. 2022 Aug;110(2 Suppl):19-25. doi: 10.12788/cutis.0579.
5
Review article: paradoxical psoriasis as a consequence of tumour necrosis factor antagonists in patients with inflammatory bowel disease.综述文章:肿瘤坏死因子拮抗剂治疗炎症性肠病患者导致的矛盾性银屑病。
Aliment Pharmacol Ther. 2022 Jun;55(11):1379-1388. doi: 10.1111/apt.16883. Epub 2022 Mar 21.
6
Clinical Disease Measures in Generalized Pustular Psoriasis.泛发性脓疱型银屑病的临床疾病指标。
Am J Clin Dermatol. 2022 Jan;23(Suppl 1):39-50. doi: 10.1007/s40257-021-00653-0. Epub 2022 Jan 21.
7
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.泛发性脓疱型银屑病患者的治疗选择和目标。
Am J Clin Dermatol. 2022 Jan;23(Suppl 1):51-64. doi: 10.1007/s40257-021-00658-9. Epub 2022 Jan 21.
8
Diagnosis of Generalized Pustular Psoriasis.泛发性脓疱型银屑病的诊断。
Am J Clin Dermatol. 2022 Jan;23(Suppl 1):31-38. doi: 10.1007/s40257-021-00652-1. Epub 2022 Jan 21.
9
Recalcitrant paradoxical pustular psoriasis induced by infliximab: Two case reports.英夫利昔单抗诱发的顽固性脓疱型银屑病:两例病例报告。
World J Clin Cases. 2021 May 26;9(15):3655-3661. doi: 10.12998/wjcc.v9.i15.3655.
10
An update on genetic basis of generalized pustular psoriasis (Review).泛发性脓疱型银屑病的遗传学基础研究进展(综述)。
Int J Mol Med. 2021 Jun;47(6). doi: 10.3892/ijmm.2021.4951. Epub 2021 May 6.